Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Peter L, Gross"'
Autor:
Sam Schulman, Aurélien Delluc, Jameel Abdulrehman, Susan Kahn, Jean-Philippe Galanaud, Ilia Makedonov, Peter L Gross
Publikováno v:
BMJ Open, Vol 13, Iss 10 (2023)
Introduction The post-thrombotic syndrome (PTS) is a form of chronic venous insufficiency due to a prior ipsilateral deep venous thrombosis (DVT). This is a frequent complication that develops in 20%–50% of patients after a proximal DVT and is asso
Externí odkaz:
https://doaj.org/article/8ac82595b200489eb6d2c435395a7049
Autor:
Jenna E. van Leeuwen, Wail Ba-Alawi, Emily Branchard, Jennifer Cruickshank, Wiebke Schormann, Joseph Longo, Jennifer Silvester, Peter L. Gross, David W. Andrews, David W. Cescon, Benjamin Haibe-Kains, Linda Z. Penn, Deena M. A. Gendoo
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Statins are promising for breast cancer therapy; dipyridamole can potentiate their effects, but is contraindicated in some cases. Here, the authors develop a pharmacogenomics pipeline to predict other compounds that potentiate statins, and validate t
Externí odkaz:
https://doaj.org/article/f57984f909454f0787ee786ab65589d9
Autor:
Maura Marcucci, Thomas W. Painter, David Conen, Kate Leslie, Vladimir V. Lomivorotov, Daniel Sessler, Matthew T. V. Chan, Flavia K. Borges, Maria J. Martínez Zapata, C. Y. Wang, Denis Xavier, Sandra N. Ofori, Giovanni Landoni, Sergey Efremov, Ydo V. Kleinlugtenbelt, Wojciech Szczeklik, Denis Schmartz, Amit X. Garg, Timothy G. Short, Maria Wittmann, Christian S. Meyhoff, Mohammed Amir, David Torres, Ameen Patel, Emmanuelle Duceppe, Kurtz Ruetzler, Joel L. Parlow, Vikas Tandon, Michael K. Wang, Edith Fleischmann, Carisi A. Polanczyk, Raja Jayaram, Sergey V. Astrakov, Mangala Rao, Tomas VanHelder, William K. K. Wu, Chao Chia Cheong, Sabry Ayad, Marat Abubakirov, Mikhail Kirov, Keyur Bhatt, Miriam de Nadal, Valery Likhvantsev, Pilar Paniagua Iglesisas, Hector J. Aguado, Michael McGillion, Andre Lamy, Richard P. Whitlock, Pavel Roshanov, David Stillo, Ingrid Copland, Jessica Vincent, Kumar Balasubramanian, Shrikant I. Bangdiwala, Bruce Biccard, Andrea Kurz, Sadeesh Srinathan, Shirley Petit, John Eikelboom, Toby Richards, Peter L. Gross, Pascal Alfonsi, Gordon Guyatt, Emily Belley-Cote, Jessica Spence, William McIntyre, Salim Yusuf, P. J. Devereaux
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background For patients undergoing noncardiac surgery, bleeding and hypotension are frequent and associated with increased mortality and cardiovascular complications. Tranexamic acid (TXA) is an antifibrinolytic agent with the potential to r
Externí odkaz:
https://doaj.org/article/ac890204cd84433d8ed555ab388c2508
Autor:
Maura Marcucci, Emmanuelle Duceppe, Yannick Le Manach, Clive Kearon, John W. Eikelboom, Kayla Pohl, Jessica Vincent, Saeed Darvish-Kazem, Sadeesh K. Srinathan, John D. D. Neary, Joel L. Parlow, Andrea Kurz, Peter L. Gross, Marko Mrkobrada, Kumar Balasubramanian, Daniel I. Sessler, P. J. Devereaux
Publikováno v:
Pilot and Feasibility Studies, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background Surgical bleeding is associated with postoperative cardiovascular complications. The efficacy and safety of tranexamic acid (TXA) in noncardiac surgery are still uncertain. Statins may prevent perioperative cardiovascular complica
Externí odkaz:
https://doaj.org/article/84e856b69c23451d9685b820434a1303
Autor:
Peter L. Gross, Noel C. Chan
Publikováno v:
Frontiers in Medicine, Vol 7 (2021)
Arterial and venous thromboembolism are both more common in older adults. The use of anticoagulants, the mainstay to prevent thromboembolism, requires consideration of the balance between risk and benefit. Such consideration is even more important in
Externí odkaz:
https://doaj.org/article/491c56b0241c4e8caf59d39bae576c4b
Autor:
Peter L. Gross, Ilia Makedonov, Aurélien Delluc, Jameel Abdulrehman, Susan R. Kahn, Jean Philippe Galanaud, Sam Schulman
Publikováno v:
Thrombosis and Haemostasis. 122:1255-1264
The postthrombotic syndrome (PTS) is chronic venous insufficiency secondary to a prior deep vein thrombosis (DVT). It is the most common complication of venous thromboembolism (VTE) and, while not fatal, it can lead to chronic, unremitting symptoms a
Autor:
Ville Sallinen, Kirsi-Maija Kaukonen, Philip J. Devereaux, Lauri I Lavikainen, Kari A.O. Tikkinen, Per Morten Sandset, Gordon H. Guyatt, Tuomas P. Kilpeläinen, Philippe D. Violette, Saana Horstia, Rufus Cartwright, Peter L. Gross
Publikováno v:
European Urology Focus. 7:1222-1225
ARTS will be the first trial to compare anticoagulation with a direct oral anticoagulant (apixaban) versus no anticoagulation among patients undergoing intra-abdominal, gynecologic, or urologic surgery at sufficiently similar risk of deep vein thromb
Autor:
Stephanie Carlin, Peter L. Gross
Publikováno v:
JACC: CardioOncology. 5:201-202
Autor:
Alannah Smrke, Peter L. Gross
Publikováno v:
Frontiers in Medicine, Vol 4 (2017)
Patients with cancer are at significantly higher risk of developing, and dying from, venous thromboembolism (VTE). The CLOT trial demonstrated superiority of low-molecular-weight heparins (LMWH) over warfarin for recurrent VTE and established LMWH as
Externí odkaz:
https://doaj.org/article/69b4ac18613a4c5190441edbd7156bc1
Autor:
Ying (Crystal) Dai, Peter L. Gross
Publikováno v:
Blood. 140:11279-11280